The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A - Concepedia

Concepedia

Publication | Open Access

The anti-tumor and renoprotection study of E-[c(RGDfK)2]/folic acid co-modified nanostructured lipid carrier loaded with doxorubicin hydrochloride/salvianolic acid A

DOI Full Paper Access

22

Citations

50

References

2022

Year

Bing Zhang, Ying Zhang, Wenli Dang, Bin Xing, Changxiang Yu, Pan Guo, Jiaxin Pi, Xiuping Deng, Dongli Qi, Zhidong Liu

Journal of Nanobiotechnology

Abstract

The E-[c(RGDfK)<sub>2</sub>]/FA co-modified DOX/Sal A multifunctional nano-drug delivery system has a good therapeutic effect on tumors and low nephrotoxicity and is a promising anti-cancer strategy.

References

	Year	Citations

Page 1